The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Inotiv's share price is $4.17.
Inotiv's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $22.73. Hence, Inotiv's PS Ratio for today is 0.18.
The historical rank and industry rank for Inotiv's PS Ratio or its related term are showing as below:
NOTV'
s PS Ratio Range Over the Past 10 Years
Min: 0.08 Med: 0.65 Max: 8.76
Current: 0.18
During the past 13 years, Inotiv's highest PS Ratio was 8.76. The lowest was 0.08. And the median was 0.65.
NOTV's PS Ratio is ranked better than 98.18% of 220
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.9
vs NOTV: 0.18
Inotiv's Revenue per Sharefor the
three
months ended in Dec. 2023 was $5.26.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $22.73.
Warning Sign:
Inotiv Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Inotiv was -1.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 58.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 54.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 23.70% per year.
During the past 13 years, Inotiv's highest 3-Year average Revenue per Share Growth Rate was 74.90% per year. The lowest was -23.40% per year. And the median was 6.85% per year.
Back to Basics: PS Ratio
Inotiv PS Ratio Historical Data
The historical data trend for Inotiv's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Inotiv's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inotiv's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's PS Ratio distribution charts can be found below:
* The bar in red indicates where Inotiv's PS Ratio falls into.
Inotiv PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Inotiv's Share Price of today is $4.17. Inotiv's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Inotiv PS Ratio Related Terms
Thank you for viewing the detailed overview of Inotiv's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NOTV has been successfully added to your 